Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,677,140
+$1,428,464 QoQ
Shares Held
201,822
+760.3% QoQ
Ownership
0.309%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 198 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Derivatives in ARVN
reported options exposure · as of Jun 30, 2025CallValue
$113,344
CallShares
15,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. ARVN ranks #82 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in ARVN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,677,140 | 201,822 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $248,676 | 23,460 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $113,344 | 15,400 | Call | Defined | 2025-08-27 | |
| 2025-03-31 | $963,586 | 137,263 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $318,011 | 16,589 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $201,285 | 10,500 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $4,183,356 | 169,848 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,165,091 | 118,899 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,379,634 | 81,871 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $271,738 | 6,602 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $963,106 | 49,038 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,216,128 | 89,288 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,051,137 | 38,475 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $1,690,130 | 37,989 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,181,456 | 75,587 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,920,742 | 28,540 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $454,973 | 5,539 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,408,613 | 29,309 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,451,912 | 18,856 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $965,324 | 14,604 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,390,269 | 28,144 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,753,302 | 74,261 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $893,036 | 26,626 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||